Cocrystal Pharma Initiates Enrollment in Phase 1 Influenza A Study with Novel, Broad-Spectrum, Orally Administrated Antiviral CC-42344

3 years ago

BOTHELL, Wash., March 10, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces dosing of…

BioRestorative Therapies Announces Research Collaboration with Professor Tore Bengtsson to Evaluate Heat Production of its ThermoStem® Program

3 years ago

MELVILLE, N.Y., March 10, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage…

Immutep Receives Constructive Feedback from US FDA on its Clinical Development Program for EFTI in Metastatic Breast Cancer

3 years ago

SYDNEY, AUSTRALIA, March 10, 2022 (GLOBE NEWSWIRE) --  Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), is pleased…

RAPT Therapeutics Reports Fourth Quarter and Year End 2021 Financial Results

3 years ago

Company maintains strong cash position of $189.7 millionSOUTH SAN FRANCISCO, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc.…

Augmedix Announces New Board Member, Laurie McGraw

3 years ago

Laurie McGraw, Former Allscripts Executive, Joins the Augmedix Board of DirectorsSAN FRANCISCO, March 10, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc.…

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2021 and Provides Corporate Update

3 years ago

Company to host conference call at 4:30 PM EST today, March 10, 2022SEATTLE and VANCOUVER, British Columbia, March 10, 2022…

Selecta Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

3 years ago

– U.S. Food and Drug Administration (“FDA”) removed clinical hold on SEL-302 for the treatment of patients with methylmalonic acidemia…

Landos Biopharma Appoints Roger Adsett to its Board of Directors

3 years ago

BLACKSBURG, Va., March 10, 2022 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmaceutical company developing novel, oral…

Windtree to Present at Oppenheimer’s 32nd Annual Healthcare Conference

3 years ago

WARRINGTON, Pa., March 10, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused…

Accelus Announces Successful First Surgeries Using Remi Robotic Navigation System with LineSider Spinal System

3 years ago

Innovative new robotic targeting and navigation system provides precision, accessibilityPALM BEACH GARDENS, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- Accelus,…